PI3K-mTOR in Cancer and Cancer Therapy

Published by: Humana Press, Inc  

People

Groups

  1. Breast Cancer Disease Management Team (1)
  2. Breast Medicine Service (1)
  3. Human Oncology and Pathogenesis Program (1)
  4. Solid Tumor Oncology Division (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.

PI3K-mTOR in Cancer and Cancer Therapy – authorized name for:

Name ISSN / ISBN Publisher
Cancer Drug Discovery and Development 2196-9906 Humana Press, Inc
Cancer Drug Discovery and Development 2196-9906 Humana Press, Inc
Cancer Drug Discovery and Development. Targets for cancer chemotherapy: Transcription factors and other nuclear proteins 0-89603-938-2 Humana Press Inc
Pi3k-Mtor in Cancer and Cancer Therapy 978-3-319-34209-2 Springer
Pi3k-Mtor in Cancer and Cancer Therapy 978-3-319-34209-2 Springer
PI3K-mTOR in Cancer and Cancer Therapy 978-3-319-34209-2 Humana Press, Inc
Resistance to PI3K Pathway Inhibition 978-3-319-34209-2 Springer
Unknown (2196-9906) 2196-9906 Humana Press, Inc